These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
437 related items for PubMed ID: 30192023
1. Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia. Tedeschi A, Conticello C, Rizzi R, Benevolo G, Laurenti L, Petrucci MT, Zaja F, Varettoni M. Hematol Oncol; 2019 Apr; 37(2):117-128. PubMed ID: 30192023 [Abstract] [Full Text] [Related]
2. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients. Cao XX, Meng Q, Mao YY, Su W, Zhen JF, Shen KN, Zhang CL, Huang XF, Duan MH, Zhang W, Zhu TN, Cai HC, Chen M, Zhou DB, Li J. Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065 [Abstract] [Full Text] [Related]
3. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Cao XX, Meng Q, Cai H, He TH, Zhang CL, Su W, Sun J, Li Y, Xu W, Zhou DB, Li J. Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994 [Abstract] [Full Text] [Related]
4. Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors. Varettoni M, Zibellini S, Capello D, Arcaini L, Rossi D, Pascutto C, Rattotti S, Mangiacavalli S, Pochintesta L, Gotti M, Gaidano G, Cazzola M. Leuk Lymphoma; 2013 Nov; 54(11):2485-9. PubMed ID: 23442064 [Abstract] [Full Text] [Related]
5. Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders. Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL, Rajkumar SV, Kyle RA, Kourelis T, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Ansell SM, Gonsalves WI, Thompson CA, Fervenza FC, Zand L, Hwa YL, Jevremovic D, Shi M, Leung N. Clin J Am Soc Nephrol; 2018 Jul 06; 13(7):1037-1046. PubMed ID: 29848505 [Abstract] [Full Text] [Related]
6. Serum markers in the differential diagnosis of Waldenstrom macroglobulinemia and other IgM monoclonal gammopathies. Zou H, Yang R, Liao ZX, Qin TD, Chen P, Zhang BY, Cao YP, Huang HF. J Clin Lab Anal; 2019 Mar 06; 33(3):e22827. PubMed ID: 30485557 [Abstract] [Full Text] [Related]
7. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM). Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV. Clin Lymphoma Myeloma Leuk; 2011 Feb 06; 11(1):74-6. PubMed ID: 21454195 [Abstract] [Full Text] [Related]
8. Clinical and clonal characteristics of monoclonal immunoglobulin M-associated type I cryoglobulinaemia. Khwaja J, Vos JMI, Pluimers TE, Japzon N, Patel A, Salter S, Kwakernaak AJ, Gupta R, Rismani A, Kyriakou C, Wechalekar AD, D'Sa S. Br J Haematol; 2024 Jan 06; 204(1):177-185. PubMed ID: 37726004 [Abstract] [Full Text] [Related]
9. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ]. Adam Z, Krejčí M, Pour L, Sevčíková E, Křivanová A, Rehák Z, Koukalová R, Cermáková Z, Vaníček J, Sevčíková S. Vnitr Lek; 2014 Oct 06; 60(10):861-79. PubMed ID: 25382009 [Abstract] [Full Text] [Related]
10. When a Monoclonal Gammopathy Is Not Multiple Myeloma. Derman B, Castillo JJ, Sarosiek S, Beksac M. Am Soc Clin Oncol Educ Book; 2022 Apr 06; 42():1-10. PubMed ID: 35394823 [Abstract] [Full Text] [Related]
11. A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders. Varettoni M, Zibellini S, Boveri E, Klersy C, Candido C, Rattotti S, Ferretti VV, Defrancesco I, Mangiacavalli S, Nizzoli ME, Flospergher E, Zerbi C, Bergamini F, Benvenuti P, Brociner M, Merati G, Paulli M, Arcaini L. Br J Haematol; 2019 Nov 06; 187(4):441-446. PubMed ID: 31276195 [Abstract] [Full Text] [Related]
12. Characteristics and Prognosis of Patients with Immunoglobulin M Monoclonal Gammopathy. Tanaka H, Sakuma Y, Ikeda H, Shimizu R, Sugita Y, Iwai R. J Clin Exp Hematop; 2017 Nov 06; 57(2):47-53. PubMed ID: 29021514 [Abstract] [Full Text] [Related]
16. Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment. Rajkumar SV, Dispenzieri A, Kyle RA. Mayo Clin Proc; 2006 May 01; 81(5):693-703. PubMed ID: 16706268 [Abstract] [Full Text] [Related]
17. Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemia. Kristinsson SY, Björkholm M, Landgren O. Clin Lymphoma Myeloma Leuk; 2013 Apr 01; 13(2):187-90. PubMed ID: 23490991 [Abstract] [Full Text] [Related]
18. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X, Morra E, Trojani A, Greco A, Arcaini L, Varettoni M, Brown JR, Tai YT, Anderson KC, Munshi NC, Patterson CJ, Manning RJ, Tripsas CK, Lindeman NI, Treon SP. Blood; 2013 Mar 14; 121(11):2051-8. PubMed ID: 23321251 [Abstract] [Full Text] [Related]